Related Experiment Video

Updated: Jun 25, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Evidence-based approach to challenging issues in the management of invasive aspergillosis

N Singh1

  • 1University of Pittsburgh, Pittsburgh, PA, USA. nis5@pitt.edu

Medical Mycology
|March 3, 2009
PubMed

Insights

Managing invasive aspergillosis is complex. This review covers disease progression during antifungal treatment, addressing worsening infections, and antifungal use in immunosuppressed patients, highlighting the need for combination therapy research.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Invasive aspergillosis presents significant management challenges.
  • Optimal therapeutic strategies remain incompletely defined, particularly in immunocompromised populations.
  • Understanding disease evolution under antifungal pressure is crucial.

Purpose of the Study:

  • To review current knowledge on invasive aspergillosis management.
  • To discuss disease progression during antifungal therapy.
  • To explore therapeutic approaches for refractory or worsening cases in iatrogenically immunosuppressed patients.

Main Methods:

  • Literature review of evidence-based studies.
  • Analysis of disease evolution patterns.
  • Evaluation of antifungal agent considerations.

Main Results:

  • Disease can evolve despite initial antifungal therapy.
  • Worsening disease requires careful re-evaluation of treatment.
  • Specific considerations exist for antifungal use in immunosuppressed patients.

Conclusions:

  • Further evidence-based studies are essential.
  • Critical issues in combination therapy require resolution.
  • Optimizing antifungal strategies for invasive aspergillosis is ongoing.

More Related Videos

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...